1. Home
  2. BREA vs CERO Comparison

BREA vs CERO Comparison

Compare BREA & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • CERO
  • Stock Information
  • Founded
  • BREA 2022
  • CERO 2017
  • Country
  • BREA Ireland
  • CERO United States
  • Employees
  • BREA N/A
  • CERO N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • CERO
  • Sector
  • BREA Consumer Discretionary
  • CERO
  • Exchange
  • BREA Nasdaq
  • CERO Nasdaq
  • Market Cap
  • BREA 8.7M
  • CERO 8.4M
  • IPO Year
  • BREA 2023
  • CERO N/A
  • Fundamental
  • Price
  • BREA $0.64
  • CERO $2.04
  • Analyst Decision
  • BREA
  • CERO
  • Analyst Count
  • BREA 0
  • CERO 0
  • Target Price
  • BREA N/A
  • CERO N/A
  • AVG Volume (30 Days)
  • BREA 109.2K
  • CERO 1.3M
  • Earning Date
  • BREA 01-03-2025
  • CERO 02-20-2025
  • Dividend Yield
  • BREA N/A
  • CERO N/A
  • EPS Growth
  • BREA N/A
  • CERO N/A
  • EPS
  • BREA N/A
  • CERO N/A
  • Revenue
  • BREA $2,872,101.00
  • CERO N/A
  • Revenue This Year
  • BREA N/A
  • CERO N/A
  • Revenue Next Year
  • BREA N/A
  • CERO N/A
  • P/E Ratio
  • BREA N/A
  • CERO N/A
  • Revenue Growth
  • BREA 2338.69
  • CERO N/A
  • 52 Week Low
  • BREA $0.50
  • CERO $1.76
  • 52 Week High
  • BREA $3.00
  • CERO $1,238.00
  • Technical
  • Relative Strength Index (RSI)
  • BREA 41.48
  • CERO 32.64
  • Support Level
  • BREA $0.62
  • CERO $1.76
  • Resistance Level
  • BREA $0.75
  • CERO $3.18
  • Average True Range (ATR)
  • BREA 0.05
  • CERO 0.35
  • MACD
  • BREA -0.01
  • CERO 0.28
  • Stochastic Oscillator
  • BREA 22.96
  • CERO 4.72

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: